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Background: Numerous, often multi-faceted regimens are available for treating complex wounds, yet the evidence
of these interventions is recondite across the literature. We aimed to identify effective interventions to treat
complex wounds through an overview of systematic reviews.
Methods: MEDLINE (OVID interface, 1946 until October 26, 2012), EMBASE (OVID interface, 1947 until October 26,
2012), and the Cochrane Database of Systematic Reviews (Issue 10 of 12, 2012) were searched on October 26, 2012.
Systematic reviews that examined adults receiving care for their complex wounds were included. Two reviewers
independently screened the literature, abstracted data, and assessed study quality using the Assessment of Multiple
Systematic Reviews (AMSTAR) tool.
Results: Overall, 99 systematic reviews were included after screening 6,200 titles and abstracts and 422 full-texts;
54 were systematic reviews with a meta-analysis (including data on over 54,000 patients) and 45 were systematic
reviews without a meta-analysis. Overall, 44% of included reviews were rated as being of high quality (AMSTAR
score ≥8). Based on data from systematic reviews including a meta-analysis with an AMSTAR score ≥8, promising
interventions for complex wounds were identified. These included bandages or stockings (multi-layer, high
compression) and wound cleansing for venous leg ulcers; four-layer bandages for mixed arterial/venous leg ulcers;
biologics, ultrasound, and hydrogel dressings for diabetic leg/foot ulcers; hydrocolloid dressings, electrotherapy,
air-fluidized beds, and alternate foam mattresses for pressure ulcers; and silver dressings and ultrasound for
unspecified mixed complex wounds. For surgical wound infections, topical negative pressure and vacuum-assisted
closure were promising interventions, but this was based on evidence from moderate to low quality systematic reviews.
Conclusions: Numerous interventions can be utilized for patients with varying types of complex wounds, yet few
treatments were consistently effective across all outcomes throughout the literature. Clinicians and patients can use our
results to tailor effective treatment according to type of complex wound. Network meta-analysis will be of benefit to
decision-makers, as it will permit multiple treatment comparisons and ranking of the effectiveness of all interventions.
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Chronic wounds are those that have not progressed
through the ordered process of healing to yield a func-
tional result [1]. Recently, the terminology for chronic
wounds has changed. The preferred term to refer to a
chronic wound is a “complex wound” [2]. One of the fol-
lowing characteristics is necessary for a wound to be clas-
sified as being complex: i) has not healed in 3 months, ii)
infection is present, iii) compromised viability of superfi-
cial tissues, necrosis, or circulation impairment, and iv) as-
sociation with systemic pathologies, impairing normal
healing [2]. The main types of complex wounds include
diabetic leg/foot ulcers, pressure ulcers [3], chronic ven-
ous ulcers, infected wounds [1,4,5], and those related to
vasculitis and immunosuppressive therapy that have not
healed using simple care [2].
Complex wounds are a significant burden on society.
It has been estimated that complex wounds cost the
healthcare system $10 billion annually in North America
alone [6]. These estimates often fail to capture indirect
costs, including patient/caregiver frustration, economic
loss, and decreased quality of life.
Healthcare providers and patients have numerous regi-
mens available for treating wounds [7], including dress-
ings, wound cleansing agents, skin replacement therapy,
biologic agents, stockings, nutritional supplementation,
complementary and alternative medicine, bandages, and
surgery, to name a few. Furthermore, wound care is
often multi-faceted, and several interventions may be
used concurrently. Some of these interventions have
been examined in overviews of Cochrane reviews [8,9].
As the evidence of these interventions is recondite
across the literature, we sought to elucidate optimal
treatment strategies for complex wounds through an
overview of all available systematic reviews, including
Cochrane reviews and non-Cochrane reviews.
Methods
Protocol
A protocol for our overview of reviews was developed
using the Cochrane Handbook for overviews of reviews
[10]. The draft protocol was circulated for feedback from
systematic review methodologists, policy-makers, and
clinicians with expertise in wound care. It was revised as
necessary and the final version is available from the cor-
responding author upon request.
Eligibility criteria
We included systematic reviews that focused on inter-
ventions to treat complex wounds (including venous and
arterial ulcers due to chronic illness, diabetic ulcers,
pressure ulcers, and infected surgical wounds) amongst
adults aged 18 years and older. We used the definition for a
systematic review put forth by the Cochrane Collaboration,“A systematic review attempts to collate all empirical
evidence that fits pre-specified eligibility criteria in order to
answer a specific research question. It uses explicit, system-
atic methods that are selected with a view to minimizing
bias, thus providing more reliable findings from which con-
clusions can be drawn and decisions made” [10].
A list of the 14 different intervention categories can be
found in Additional file 1. All comparators, such as other
wound care interventions, no treatment, placebo, and
usual care were eligible for inclusion. To be included, a
systematic review also had to report on our outcomes of
interest as identified by decision-makers, including healing
(e.g., number of ulcers healed, improvement of ulcers, and
time to ulcer healing) or admission to hospital (including
readmissions). Systematic reviews that were published or
unpublished and conducted at any point in time were in-
cluded. Due to resource limitations, only systematic re-
views written in English were included. However, authors
were contacted to obtain translations of reviews written in
languages other than English.
Literature search
Comprehensive literature searches were conducted from
inception until October 2012 across MEDLINE, EMBASE,
and the Cochrane Database of Systematic Reviews. The
search terms included both medical subject headings
(MeSH) and free text terms related to wound care inter-
ventions. Literature searches were conducted by an experi-
enced librarian (LP) on October 26, 2012. Using validated
search filters, the search strategies were limited to human
participants, adults, and systematic reviews. The electronic
database search was supplemented by searching for sys-
tematic review protocols in the PROSPERO database [11],
contacting authors of conference proceeding abstracts for
their unpublished data, and scanning the reference lists of
the included systematic reviews.
The search strategy was peer reviewed by another expert
librarian on our team (EC) using the Peer Review of Elec-
tronic Search Strategies checklist [12] and amended, as
necessary. The final search strategy for the MEDLINE
database is presented in Additional file 2. The literature
search was limited to adults, reviews, and economic stud-
ies. The latter limitation was employed to identify cost-
effectiveness analyses for a second paper that examines
the cost-effectiveness of complex wounds [Tricco et al.,
unpublished paper submitted to BMC Medicine]. The
MEDLINE search was modified for the other two data-
bases, as necessary. Search strategies for the EMBASE and
Cochrane Database of Systematic Reviews are available
from the corresponding author, upon request.
Screening
Prior to commencing the screening process, a calibration
exercise was conducted to ensure reliability in correctly
Figure 1 Study flow. Details the flow of information through the
different phases of the review. The flow maps out the number of
records identified, included and excluded, and the reasons for
their exclusion.
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screening a random sample of 50 of the included titles
and abstracts by all team members, independently. The
eligibility criteria were modified, as necessary, to
optimize clarity. Subsequently, reviewer pairs (ACT, JA,
AH, AV, PAK, CW, EC, LP) independently screened the
remainder of the search results for inclusion using a pre-
defined relevance criteria form for all levels of screening
(e.g., title and abstract, full-text review of potentially
relevant articles). Discrepancies were resolved by discus-
sion or the involvement of a third reviewer.
Data items
Data abstraction forms were pilot-tested by all team
members independently on a random sample of five arti-
cles. The data abstraction forms were revised after this
exercise, as necessary. Subsequently, reviewer pairs
(ACT, JA, AH, AV, PAK, CW, LP, WH) independently
read each article and abstracted relevant data. Differ-
ences in abstraction were resolved by discussion or the
involvement of a third reviewer. Data items included
study characteristics (e.g., number of studies identified,
type of study designs included, interventions and com-
parators examined), patient characteristics (e.g., clinical
population, wound types, age category), and outcome re-
sults (e.g., healing, hospitalizations).
Methodological quality appraisal
The methodological quality of the included systematic
reviews were appraised using the Assessment of Multiple
Systematic Reviews (AMSTAR) tool [13]. The reliability
and validity of this tool has been established [14]. Items
include the use of a protocol, study selection by two re-
viewers, comprehensive literature search, inclusion of
unpublished material, list of included and excluded stud-
ies, reporting of study characteristics, quality appraisal,
appropriate pooling of data methods, assessment of pub-
lication bias, and statement of conflicts of interest. Each
included systematic review was appraised by two team
members (ACT, JA, AH, AV, PAK, CW, EC, LP) and
conflicts were resolved by discussion or the involvement
of a third reviewer.
Synthesis
Literature search results and the abstracted data were
summarized descriptively. An in-depth comparison of
included systematic reviews was compiled and depicted
in tables and figures. Conclusion statements for system-
atic reviews without a meta-analysis were categorized by
two reviewers (ACT, JA, AH, AV, PAK, CW, LP, WH),
independently, using a pre-existing framework, as fol-
lows: positive (authors stated that there is evidence of ef-
fectiveness); neutral (no evidence of effectiveness or they
reported no opinion); negative (authors advised againstthe use of the intervention or it was not recommended);
or indeterminate (authors stated that there is insufficient
evidence or that more research is required) [15]. Con-
flicts were resolved through discussion and a third re-




The literature search resulted in 6,200 titles and ab-
stracts, of which 5,778 were excluded for not fulfilling
the eligibility criteria (Figure 1). Of the 422 full-texts re-
trieved and screened in duplicate, 309 articles were ex-
cluded. Ninety-nine systematic reviews of wound care
interventions were included in this overview of system-
atic reviews; 54 were systematic reviews with meta-
analysis results [16-67] and 45 were systematic reviews
without a meta-analysis [68-112]. In addition, 14 com-
panion reports were included [21,113-125], the majority
of which were Cochrane updates.
Systematic review characteristics
The reviews were conducted between 1997 and 2012, with
28% taking place after 2011 (Table 1; Additional file 3).
















Europe (38 of these are from the
United Kingdom)
65 65.7
North America 19 19.2
Australasia (Australia, New Zealand) 7 7.1
Asia (Malaysia, China, Taiwan, India) 6 6.1
South America 2 2.0









Randomized clinical trials 93 70.5
Observational studies




Time series 2 1.5
Patient population
Not specifically reported 65 65.7
Diabetes 21 21.2
Chronic venous disease 4 4.0
Complex lower limb wounds 4 4.0
Inpatients/institutionalized 3 3.0
Ambulatory patients 1 1.0
Elderly 1 1.0
Type of wound*
Venous leg ulcers 36 31.3
Diabetic foot/leg ulcers 26 22.6
Pressure ulcers 20 17.4
Mixed arterial/venous leg ulcers 16 13.9
Mixed complex wound unspecified 10 8.7
Infected surgical wounds 7 7.0






Other topical 14 8.6
Other oral 11 6.8
Stockings 10 6.1
Support surfaces 10 6.1
Wound cleansing 10 6.1
Skin replacement 9 5.5
Bandages 7 4.3
Surgery 7 4.3
Nutritional supplementation 4 2.5
Wound care program 4 2.5
Complementary and alternative medicine
2 1.2
Comparators examined*
Usual care 63 45.7
Dressings 34 24.6
Bandages 8 5.8
Not reported 8 5.8
Support surfaces 7 5.1
Other topical 5 3.6
Wound cleansing 5 3.6
Stockings 4 2.9
Other oral 2 1.5
All other treatments 1 0.7
Skin replacement 1 0.7
Number of treatment comparisons
per outcome
Systematic reviews with a meta-analysis n = 143 comparisons %
Wound area/size reduction 10 7.0
Time to healing or rate of healing 10 7.0
Ulcer healing 20 14.0
Proportion of patients with healed
wounds
97 67.8
No healing improvement 5 3.5
Length of hospitalization 1 0.7
Systematic reviews without a meta-analysis n = 184 comparisons %
Wound area/size reduction 18 9.8
Time to healing or rate of healing 53 28.8
Ulcer healing 92 50.0
Proportion of patients with healed
wounds
21 11.4
*Numbers do not add up to 99, as the systematic reviews contributed data to
more than one category.
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predominantly based in Europe (66%), North America
(19%), and Australia or New Zealand (7%). The number of
studies included in each review ranged from 0 to
130, with 80% including between 2 and 30 studies.
Ninety-three systematic reviews included randomized
clinical trials. Five systematic reviews were unpublished
[43,58,83,104,106].Study and patient characteristics
Thirty-four systematic reviews provided information
about the patient population under study (Table 1;
Additional file 3) and 21% included patients with dia-
betes. Six categories of complex wounds were examined:
venous leg ulcers (31%), diabetic foot/leg ulcers (23%),
pressure ulcers (17%), mixed arterial/venous leg wounds
(14%), unspecified mixed complex wounds (9%), and in-
fected surgical wounds (6%). The five most common in-
terventions were adjuvant therapies (20%), dressings
(16%), biologic agents (10%), other topical agents (9%),
and other oral agents (7%). The five most common com-
parators were usual care (46%), dressings (25%), ban-
dages (6%), support surfaces (5%), and other topical
agents (4%). The duration of treatment ranged from
2 days to 160 months and the duration of follow-up
ranged from 2 days to 195 months across the included
studies in the systematic reviews.
A total of 327 treatment comparisons were included in
the 99 systematic reviews. As such, only statistically sig-
nificant results from systematic reviews with a meta-
analysis are reported in our outcome results section
below in the text. Specific results for all treatment com-
parisons can be found in Table 2. To facilitate the sum-
mary and comparison of a large number of reviews, we
have presented the review results using positive, nega-
tive, or neutral conclusions (Tables 2,3,4,5,6,7); however,
we have also included the statistical effect sizes from
each of the included meta-analyses in Additional file 4.Methodological quality appraisal
Almost half (45%) of the systematic reviews were
deemed high quality with an AMSTAR score ≥8 out of a
possible 11 (Figure 2; Additional file 5). Many system-
atic reviews did not provide a list of excluded studies
from screening potentially relevant full-text articles
(60%) or address publication bias (65%). Conversely,
95% searched at least two electronic databases, 91% pro-
vided the characteristics of included studies, and 89%
adequately used the quality appraisal results in formu-
lating conclusions. Half of the systematic reviews in-
cluding a meta-analysis had an AMSTAR score ≥8, and
40% of the systematic reviews without a meta-analysis
had an AMSTAR score ≥8.Outcome results for venous leg ulcers
Wound area/size reduction
Two systematic reviews including two meta-analyses
examined venous leg ulcer area/size reduction [56] (Table 2;
Additional file 4), one of which had an AMSTAR score ≥8
[36]. Topical cadexomer iodine [36] and oral micronized
purified flavonoid fraction [56] were more effective than pla-
cebo in each meta-analysis comparing these interventions.
Time to healing or rate of healing
Five systematic reviews including six meta-analyses
[34,39,44,45,56] and one systematic review without a
meta-analysis [77] (Table 2; Additional files 4 and 6) ex-
amined the time to healing for venous leg ulcers. Two of
these had an AMSTAR score ≥8 [44,45].
Two systematic reviews (AMSTAR score ≥8) including
two meta-analyses found that four-layer bandages were
more effective than short stretch bandages [44] and
compression systems [45]. One systematic review includ-
ing two meta-analyses found conflicting results for ban-
dages versus stockings [39]. Oral micronized purified
flavonoid fraction was more effective than placebo in
one meta-analysis [56].
Ulcer healing
Five systematic reviews including eight meta-analyses
[29,30,39,51,62] and five systematic reviews without a
meta-analysis [72,73,77,89,103] (Table 2; Additional files
4 and 6) examined venous leg ulcer healing. Four of
these had an AMSTAR score ≥8 [30,62,73,89].
Elastic high compression was more effective than
multi-layer inelastic compression in a systematic review
(AMSTAR score ≥8) with a meta-analysis [62] and
stockings were more effective than bandages in another
meta-analysis [39]. Tissue engineered skin was more ef-
fective than dressings in one meta-analysis [51], topical
granulocyte-macrophage colony stimulating factor was
more effective than placebo in another meta-analysis
[29], and oral pentoxifylline was more effective with (or
without) compression than placebo in another meta-
analysis (AMSTAR score ≥8) [30].
Proportion of patients with healed wounds
Nineteen systematic reviews with 39 meta-analyses [21,23,
25,30,31,36,40,45,46,48,52,53,55,58,62,64-67] and two sys-
tematic reviews without a meta-analysis [77,102] (Table 2;
Additional files 4 and 6) examined the proportion of
patients with healed venous leg ulcers. Twelve of these
had an AMSTAR score ≥8 [23,25,30,31,36,40,45,52,55,62,64,67].
Multi-layered, high compression bandages reduced ulcers
compared with single layer bandages in two meta-analyses
[62,67]. Elastic high compression was more effective than
inelastic bandages [45] and versus inelastic compression
bandages (AMSTAR score ≥8) [67] in two meta-analyses.
Table 2 Summary of evidence for venous ulcer management
Outcome Intervention Systematic reviews with MA Systematic reviews without MA
High-quality* Low/moderate quality High-quality** Low/moderate quality
Wound size reduction
(MAs: 2; non-MAs: NA) [36,56]
Cadexomer iodine (topical) + NA NA NA
Micronized purified flavonoid fraction (MPFF) (oral) NA + NA NA
Time to healing or rate of healing
(MAs: 5 [34,39,44,45,56];non-MAs: 1 [77])
Four-layer bandage + NA NA NA
MPFF (oral) NA + NA NA
Stockings NA + NA +/−
Silver-impregnated dressings NA – NA NA
Applied freeze-dried keratinocyte lysate (topical) NA NA NA –
Collagenase (topical) NA NA NA +/−
Compression stockings NA NA NA +
Flavonoids + compression NA NA NA +/−
Intermittent pneumatic compression + compression NA NA NA +/−
Larval therapy NA NA NA +/−
Laser therapy NA NA NA +/−
Leg ulcer clinics, wound care program NA NA NA +/−
Multi-layer elastomeric high-compression NA NA NA –
Platelet-derived growth factor (oral) NA NA NA +/−
Rutosides (oral) NA NA NA +/−
Semi-occlusive dressings: foam, film, hyaluronic
acid-derived dressings, collagen, cellulose, or alginate
NA NA NA –
Stockings: multi-layer elastic system, multi-layer
elastomeric (or non-elastomeric) high-compression
regimens
NA NA NA –
Sulodexide (oral) + compression NA NA NA +
Thromboxane α2 antagonists (oral) NA NA NA +/−
Topical negative pressure (vacuum-assisted closure) NA NA NA +




Elastic high compression bandages + NA NA +
Cryopreserved allografts (Skin grafting) NA – NA +/−
Cultured keratinocytes/epidermal grafts (Skin grafting) NA – NA +/−
Fresh allografts (Skin grafting) NA – NA +/−
Granulocyte-macrophage colony stimulating factor (topical) NA + NA NA












Table 2 Summary of evidence for venous ulcer management (Continued)
Stockings NA + NA
Tissue engineered skin NA + NA NA
Electromagnetic therapy NA NA + NA
Hydrocolloid (occlusive) dressings + compression NA NA NA –
Intermittent pneumatic compression (Flowtron, sequential
gradient Jobst extremity pump)
NA NA NA +/−
Maggot debridement therapy NA NA NA +
Mesoglycan (topical) NA NA NA +/−
Superficial venous surgery NA NA + NA
Proportion of patients with healed wounds
(MAs: 39 [21,23,25,30,31,36,40,45,46,48,52,53,55,
58,62,64-67]; non-MAs: 2 [77,102])
Four-layer bandage – NA
Any laser (unspecified low level laser, ultraviolet therapy,
non-coherent unpolarized red light)
NA – NA NA
Artificial skin graft and standard wound care NA – NA NA
Autologous platelet-rich plasma (topical) NA – NA –
Cadexomer iodine (topical) plus compression therapy + NA NA NA
Systemic ciprofloxacin (oral) NA – NA NA
Skin replacement therapy (Dermagraft) NA + NA +
Elastic high compression bandages + NA NA NA
Foam dressing – NA NA NA
Granulocyte-macrophage colony stimulating factor
(perilesional injection)
NA + NA +
High frequency ultrasound – NA NA NA
Honey (topical) – NA NA NA
Hydrocolloid dressings – NA NA NA
Hydrogel dressing – NA NA NA
Intermittent pneumatic compression stockings +/− – NA NA
Low frequency ultrasound – NA NA NA
Multi-layer high compression bandages +/− NA NA +
Pentoxifylline (oral) with and without compression + NA NA +
Stockings + NA NA +/−
Two-component (outer elastic) bandages +/− NA NA NA
Ultrasound NA – NA NA
Unna’s boot NA – NA NA












Table 2 Summary of evidence for venous ulcer management (Continued)
Antimicrobial (topical) NA NA NA –
Calcitonin gene-related peptide (topical) NA NA NA –
Prostaglandin EI (IV) NA NA NA +
Subfascial endoscopic perforator surgery NA NA NA +
Superficial vein surgery NA NA NA +/−
Systemic mesoglycan (IM, oral) + compression NA NA NA +
*At least one systematic review with meta-analysis and AMSTAR score ≥8.
**At least one systematic review without meta-analysis and AMSTAR score ≥8.
+ Effective (statistically significant difference between interventions and comparators); – No difference (no statistically significant difference between interventions and comparators); +/− Unknown (conflicting evidence












Table 3 Summary of evidence for mixed arterial/venous ulcer management
Outcome Intervention Systematic reviews with MA Systematic reviews without MA
High-quality* Low/moderate quality High-quality** Low/moderate quality
Wound area/size reduction
(MAs: 3) [34,65]
Silver treatments (topical) and silver-impregnated dressings NA +/− NA NA
Ultrasound NA + NA NA
Ulcer healing
(MAs: NA; non-MAs: 6) [80,82-84,101,110]
Antimicrobial (topical and oral) NA NA NA –
Electromagnetic therapy NA NA NA +
Honey (topical) NA NA NA +/−
Ketanserin ointment, 2% (topical) NA NA NA +/−
Standardized wound treatment protocol NA NA NA +
Silver releasing dressing NA NA – NA
Time to healing or rate of healing
(MAs: 5) [45,49,55,56]
Topical negative pressure NA + NA NA
Four-layer bandage + NA NA NA
Micronized purified flavonoid fraction (oral) NA + NA NA
Micronized purified flavonoid fraction (oral) NA + NA NA
Polyurethane (dressing) – NA NA NA
Alginate (beads, paste + dressing, alginate dressing) – NA NA NA
Proportion of patients with healed wounds
(MAs: 3) [49,50]
Silver dressings (topical or impregnated) NA – NA NA
Topical negative pressure NA + NA NA
*At least one systematic review with meta-analysis and AMSTAR score ≥8.
**At least one systematic review without meta-analysis and AMSTAR score ≥8.
+ Effective (statistically significant difference between interventions and comparators); – No difference (no statistically significant difference between interventions and comparators); +/− Unknown (conflicting evidence












Table 4 Summary of evidence for diabetic ulcer management
Outcome Intervention Systematic reviews with MA Systematic reviews without MA
High-quality* Low/moderate quality High-quality** Low/moderate quality
Wound area/size reduction
(MAs: NA; non-MAs: 2) [79,88]
Hyperbaric oxygen therapy (systemic + usual care) NA NA NA –
Stem cell therapy NA NA NA +
Time to healing or rate of healing
(MAs: NA; non-MAs: 3)
Human skin equivalent NA NA NA +
Human cultured dermis NA NA NA –
Laser therapy and complex intervention NA NA NA +/−
[79,88,95] Platelet derived growth factors (topical) NA NA NA +
Pressure off-loading, felted foam NA NA NA –
Pressure off-loading, total contact or non-removable cast NA NA NA +
Stem cell therapy NA NA NA –
Skin grafts NA NA NA –
Topical negative pressure NA NA – NA
Ulcer healing
(MAs: 4 [24,35,57]; non-MAs: 10
[69,70,74,79,81,86,88,93,112,122])
Chinese herbal medicine + standard therapy NA + NA NA
Granulocyte colony-stimulating factor (SC, IV) + antibiotics
(oral, IV)
+/− – NA +/−
Alginate, foam, hydrogel, hydrocolloid dressings NA NA NA +/−
Alginate, hydrogel, hydrocellulose, semi-permeable
membrane dressings
NA NA NA –
Amoxicillin + clavulanic acid (oral), ofloxacin, imipenem/
cilastatin, ampicillin/sulbactam (IV)
NA NA NA +/−
Antibiotics, choice based on bone biopsy (IV, oral) NA NA NA +/−
Ayurvedic preparations (oral + topical) NA NA NA +/−
Clindamycin, fluoroquinolone, rifampicin, amoxicillin/clavulanic
acid (oral, topical) +/− surgical intervention
NA NA NA +/−
Compression NA NA NA +
Cultured human dermis NA NA NA +/−
Dressings + debridement (hydrogel) NA NA NA +
Early surgical intervention + antibiotics NA NA NA +/−
Electrical stimulation NA NA NA –
Endovascular or open bypass revascularization surgery of
an ulcerated foot
NA NA NA +/−
Foot care clinic interventions NA NA NA +/−
Growth factors (topical) NA NA NA –
Hydrogel, cadexomer iodine ointment, dressings, larval
therapy, sugar (topical) systemic antibiotics












Table 4 Summary of evidence for diabetic ulcer management (Continued)
Hyperbaric oxygen therapy NA NA NA +/−
Hyperbaric oxygen therapy (systemic + usual care) NA NA NA –
Imipenem/cilastatin, cefazolin, Ampicillin/sulbactam,
Linezolid, Piperacillin/tazobactam. Amoxycillin + clavulanic
acid, clindamycin hydrochloride (oral), pexiganan cream
NA NA – NA
Ketanserin (oral, topical) NA NA NA +/−
Larval therapy NA NA NA +
Lyophilized collagen, platelets and derived products (topical) NA NA NA +
Magnet and normothermic therapy NA NA NA –
Patient education NA NA NA +/−
Percutaneous flexor tenotomy NA NA NA +/−
Procaine + polyvinylpyrrolidone (IM) NA NA NA –
Resection of the complex wound NA NA NA –
Sharp debridement NA NA NA +/−
Skin grafts NA NA NA +
Stem cell therapy NA NA NA +
Superoxidized water and soap, povidone iodine (topical) NA NA NA +/−
Therapeutic footwear NA NA NA +/−
Thrombin-induced human platelet growth factor,
recombinant platelet derived growth factor, recombinant
basic fibroblast growth factor,arginine-glycine-aspartic acid
peptide matrix (topical)
NA NA NA +/−
Topical negative pressure NA NA NA +
Negative pressure therapy NA NA NA +
Total contact casting NA NA NA +/−
Ultrasound NA NA NA –
Zinc oxide tape NA NA NA +
No healing improvement/non-healed wounds
(MAs: 5)
Chinese herbal medicine NA + NA NA
[22,33,35] Hyaluronic acid-based scaffold and keratinocytes – NA NA NA
Hyaluronic acid-based derivative + NA NA NA
Low frequency low intensity noncontact ultrasound + NA NA NA
Proportion of patients with healed wounds
(MAs: 18) [17-20,22,24,27,28,35,38,46,47,57-59]
Alginate dressing – NA NA NA
Artificial skin graft and standard care NA + NA NA












Table 4 Summary of evidence for diabetic ulcer management (Continued)
Skin graft (Dermagraft) NA – NA NA
Fibrous-hydrocolloid (hydrofibre) dressing – NA NA NA
Foam dressing – NA NA NA
Granulocyte colony-stimulating factor (SC, IV) + antibiotics
(oral, IV)
+ + NA NA
Hyaluronic acid-based scaffold and keratinocytes – NA NA NA
Hydrogel dressing + + NA NA
Hyperbaric oxygen therapy – NA NA
Platelet-rich plasma NA + NA NA
Skin replacement therapy (keratinocyte allograft, meshed
skin autograft, split thickness autograft)
NA + NA NA
*At least one systematic review with meta-analysis and AMSTAR score ≥8.
**At least one systematic review without meta-analysis and AMSTAR score ≥8.
+ Effective (statistically significant difference between interventions and comparators); – No difference (no statistically significant difference between interventions and comparators); +/− Unknown (conflicting evidence












Table 5 Summary of evidence for pressure ulcer management
Outcome Intervention Systematic reviews with MA Systematic reviews without MA
High-quality* Low/moderate quality High-quality** Low/moderate quality
Wound area/size reduction
(MAs: NA; non-MAs: 3) [78,87,94]
Air-fluidized support NA NA NA +
Alternating pressure mattress, low-air-loss mattress,
air-fluidized mattress
NA NA NA –
Collagenase NA NA NA +/−
Collagenase, hydrogel dressings NA NA NA –
Electric current, electromagnetic therapy NA NA NA –
Foam, calcium alginate, radiant heat dressing, dextranomer
powder dressings
NA NA NA –
Hydrocolloid dressings NA NA NA +
Hydrocolloid, hydrogel wafer, hydrogel, occlusive
polyurethane, transparent moisture-permeable dressings
NA NA NA –
Hydrogel, cadexomer iodine, semelil gel, radiant heat,
zinc salt spray, aluminum hydroxide, vitamin A ointment,
streptokinase-streptodornase, dialysate, topical insulin, moist
saline gauze and whirlpool, semelil dressings
NA NA NA –
Low level laser therapy, laser and standard care NA NA NA –
Polarized light, monochromatic light and cadexomer
iodine or hydrocolloid
NA NA NA –
Ultrasound NA NA NA –
Vacuum therapy NA NA NA –
Vitamin C and ultrasound, consistent wound care and
controlled nutritional support, vitamin C, zinc sulfate
NA NA NA –
Time to healing or rate of healing
(MAs: NA; non-MAs: 3) [68,78,94]
Ascorbic acid, high-protein diet, concentrated, fortified,
collagen protein hydrolysate supplement, disease-specific
nutrition treatment
NA NA NA +/−
Amorphous hydrogel dressing derived from Aloe vera
wound dressings
NA NA +/− NA
Electromagnetic therapy, low-intensity direct current,
negative-polarity and positive-polarity electrotherapy, and
alternating-polarity electrotherapy
NA NA NA +/−
Hydrocolloid dressings NA NA NA +/−
Low air-loss beds NA NA NA +/−
Low level laser therapy NA NA NA +/−
Low-tech constant low-pressure supports NA NA NA +/−
Phenytoin ointment (topical) NA NA NA +/−












Table 5 Summary of evidence for pressure ulcer management (Continued)
Topical negative pressure NA NA NA +/−
Triple antibiotic ointment, active cream dressings NA NA NA –
Ultrasound NA NA NA –
Ulcer healing
(MAs: 8 [16,43,60,62,64];non-MAs: 11
[75,76,78,85,90,92,94,97,99,104,106])
Air-fluidized bed/supports + + +/− NA
Air-fluidized beds, air suspension beds, foam replacement mattress NA NA – NA
Alternating pressure surfaces NA NA +/−
Alternating pressure surfaces (alternating pressure mattress +
pressure relief cushion)
NA NA +/− NA
Ascorbic acid, zinc sulfate NA NA +/− NA
Collagen protein, standard hospital diet and high protein,
standard hospital diet and high protein and zinc and
arginine and vitamin C
NA NA NA –
Collagenase (topical) NA NA NA +
Fibroblast-derived dermal replacement NA NA NA +
Hydrocolloid, polyurethane, dextranomer, hydrogel,
polyhydroxyethyl methacrylate, amino acid
copolymer dressings
NA NA NA –
Low air-loss mattress, alternating pressure mattress,
air-fluidized mattress
NA NA NA –
Phenytoin solution, antibiotics dressings NA NA NA –
Protease-modulating matrix, recombinant platelet-derived
growth factor BB, nerve growth factor, transforming growth
factor beta, granulocyte-macrophage/colony stimulating
factor, basic fibroblast growth factor (topical)
NA NA NA +
Saline spray containing Aloe vera, silver chloride and decyl
glucoside, saline, whirlpool
NA NA NA –
Topical negative pressure NA NA NA –
Topical negative pressure (vacuum assisted wound closure) NA NA NA –
Alternative foam mattress + NA NA NA
Electrotherapy + NA NA NA
High protein, oral nutritional support, enteral tube feeding – NA NA NA
Hydrocolloid dressings + NA NA NA
Polyurethane dressings – NA NA NA
Proportion of patients with healed wounds
(MAs: 25 [43,54,62]; non-MAs: 2 [78,94])
Collagenase debridement (topical) NA – NA NA
Dextranomer (beads + dry dressing) NA – NA NA
Electrical stimulation NA – NA NA












Table 5 Summary of evidence for pressure ulcer management (Continued)
Growth Factors (topical) NA – NA
Hydrocolloid dressings NA +/− NA –
Hydrogel (gel) NA + NA –
Hydropolymer dressing NA – NA NA
Low air-loss beds – – NA NA
Low level laser therapy NA – NA NA
Alternating pressure mattress NA +/− NA NA
Non-contact normothermic dressing NA – NA NA
Polyurethane dressings NA – NA –
Ultrasound – – NA +/−
Zinc supplement (oral) NA – NA
Collagenase, dressings NA NA NA –
Laser therapy +moist saline gauze NA NA NA –
Monochromatic phototherapy, UV light NA NA NA –
Oxyquinoline, radiant heat, soft silicone, hydrogel or foam,
active ointment with live yeast derivative, topical insulin
(dressings)
NA NA NA –
Resin salve absorbent dressings NA NA NA –
Specialized foam mattress, alternating pressure mattress NA NA NA –
*At least one systematic review with meta-analysis and AMSTAR score ≥8.
**At least one systematic review without meta-analysis and AMSTAR score ≥8.
+ Effective (statistically significant difference between interventions and comparators); – No difference (no statistically significant difference between interventions and comparators); +/− Unknown (conflicting evidence












Table 6 Summary of evidence for mixed complex wounds management
Outcome Intervention Systematic reviews with MA Systematic reviews without MA
High-quality* Low/moderate quality High-quality** Low/moderate quality
Wound area/size reduction (MAs:5) [21,32,41,42] Autologous platelet-rich plasma/platelet-rich
plasma (topical)
– – NA NA
Silver releasing dressings + NA NA NA
Topical negative pressure NA + NA NA
Ulcer healing (MA: 1 [63]; non-MAs: 5 [91,100,105,107,111]) Laser therapy NA – NA NA
Adhesive zinc oxide tape NA NA + NA
Dextranomer polysaccharide beads or paste,
cadexomer iodine polysaccharide beads or paste
NA NA _ NA
Enzymatic agents (topical) NA NA – NA
Hydrogel dressings NA NA – NA
Hyperbaric oxygen therapy NA NA NA +
No-sting barrier film bandages NA NA NA +
Silver releasing dressing, non-releasing silver-activated
charcoal dressing, hydrocolloid silver Vaseline-impregnated
dressing, silver coated dressing, hydrocolloid silver-releasing
dressing, silver-releasing foam dressing
NA NA + NA
Topical negative pressure (open-cell foam dressing
with continuous suction)
NA NA + NA
Proportion of patients with healed wounds
(MAs: 10) [21,55,58,61,62,125]
Skin replacement (skin substitute) and standard care NA + NA NA
Skin replacement (dermal substitute) and standard care NA + NA NA
Artificial skin grafts and standard care NA + NA NA
Autologous platelet-rich plasma/platelet-rich plasma (topical) NA – NA NA
Hydrocolloid dressings – + NA NA
Laser therapy – NA NA NA
Ultrasound +/− NA NA NA
*At least one systematic review with meta-analysis and AMSTAR score ≥8.
**At least one systematic review without meta-analysis and AMSTAR score ≥8.
+ Effective (statistically significant difference between interventions and comparators); – No difference (no statistically significant difference between interventions and comparators); +/− Unknown (conflicting evidence












Table 7 Summary of evidence for infected surgical wounds management





Proportion of patients with
healed wounds (MAs: 1) [37]
Topical negative pressure/
vacuum-assisted closure
NA + NA NA
Vacuum-assisted closure NA + NA NA
Wound area/size reduction
(MAs: NA; non-MAs: 2) [71,108]
Alginate dressings NA NA – NA
Foam dressings NA NA – NA
Time to healing or rate of
healing (MAs: NA; non-MAs: 5)
[68,71,96,108,109]
Alginate dressings NA NA +/− NA
Aloe vera dermal gel (topical) NA NA +/− NA
Dextranomer polysaccharide
bead dressings
NA NA +/− NA
Foam dressings NA NA – NA
Gauze + Aloe vera dressings NA NA +/− NA
Honey (topical) NA NA +
Hydrocolloid dressings NA NA – NA
Plaster casting NA NA + NA
Polyurethane foam and sheets dressings NA NA +/− NA
Silicone elastomer foam dressings
and polyurethane foam dressings
NA NA – NA
Topical negative pressure NA NA – NA




NA NA +/− NA
Polyurethane foam dressings NA NA +/− NA
*At least one systematic review with meta-analysis and AMSTAR score ≥8.
**At least one systematic review without meta-analysis and AMSTAR score ≥8.
+ Effective (statistically significant difference between interventions and comparators); – No difference (no statistically significant difference between interventions
and comparators); +/− Unknown (conflicting evidence between meta-analysis or indeterminate results); NA, No studies available; MA, Meta-analysis.
Tricco et al. BMC Medicine  (2015) 13:89 Page 17 of 23Intermittent pneumatic compression was more effective
than compression stockings or Unna’s boot in one meta-
analysis (AMSTAR score ≥8) [67] and high compression
stockings were more effective than compression bandages
in another meta-analysis (AMSTAR score ≥8) [62]. Two-
layer stockings were more effective than short-stretch ban-
dages in another meta-analysis [44]. Ultrasound was more
effective than no ultrasound in one meta-analysis [65] and
cleaning wounds with cadexomer iodine plus compression
therapy was more effective than standard care in another
meta-analysis (AMSTAR score ≥8) [36]. Skin replacement
therapy was more effective than standard compression
therapy in one meta-analysis [46] and oral pentoxifylline
with (or without) compression was more effective than
placebo in two meta-analyses (AMSTAR score ≥8) [30].
Periulcer injection with granulocyte-macrophage colony
stimulating factor was more effective than control in an-
other meta-analysis [53].
Outcome results for mixed arterial/venous leg ulcers
Wound area/size reduction
Two systematic reviews including three meta-analyses
examined wound area/size reduction for mixed arterial/venous leg ulcers [34,65] (Table 3; Additional file 4).
None had an AMSTAR score ≥8. One meta-analysis
found topical silver and silver dressings more effective
than placebo or conservative wound care or non-silver
therapies [34] and another that ultrasound was more ef-
fective than standard treatment or placebo [65].Time to healing or rate of healing
Four systematic reviews including five meta-analyses ex-
amined the time to healing for mixed arterial/venous leg
ulcers [45,49,55,56] (Table 3; Additional file 4). Two had
an AMSTAR score ≥8 [45,55]. One meta-analysis found
topical negative pressure more effective than conven-
tional therapy [49], a second found oral micronized puri-
fied flavonoid more effective than placebo or standard
compression [56], and a third found that four-layer ban-
dage was more effective than compression systems [45].Ulcer healing
Six systematic reviews without a meta-analysis examined
ulcer healing for mixed arterial/venous leg ulcers






































Yes Unclear No NA
Figure 2 AMSTAR methodological quality results. NA, Not applicable. 1. A priori design. 2. Duplicate selection/DA. 3. Literature search.
4. Publication status. 5. List of studies. 6. Study characteristics. 7. Quality assessed. 8. Quality used. 9. Methods appropriate. 10. Publication bias
assessed. 11. Conflicts stated.
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sults can be found in Additional file 6.
Proportion of patients with healed wounds
Two systematic reviews including three meta-analyses ex-
amined the proportion of patients with healed mixed ar-
terial/venous wounds [49,50] (Table 3; Additional file 4).
None had an AMSTAR score ≥8. Topical negative pres-
sure was more effective than conventional therapy in one
meta-analysis [49].
Outcome results for diabetic foot/leg ulcers
The following outcome results were only reported in
systematic reviews without meta-analysis: wound area/
size reduction (n = 2) [79,88] and time to healing or rate
of healing (n = 3) [79,88,95]. Details of these study re-
sults can be found in Additional file 6.
Ulcer healing
Three systematic reviews including four meta-analyses
[24,35,57] and 10 systematic reviews without a meta-analysis
[69,70,74,79,81,86,88,93,98,112] (Table 4; Additional files 4
and 6) examined healing improvements of diabetic foot/leg
ulcers. Three had an AMSTAR score ≥8 [24,74,98].
One meta-analysis found that subcutaneous or intraven-
ous granulocyte colony-stimulating factor plus oral or
intravenous antibiotics was more effective than control(high quality) [24]. Another meta-analysis found that
Chinese herbal medicine (see Table 4 and Additional file 4
for the exact preparation) plus unspecified standard ther-
apy was more effective than standard therapy alone [35].
No healing improvement or non-healed wounds
Three systematic reviews including five meta-analyses
[22,33,35] examined no healing improvement for dia-
betic wounds (Table 4; Additional file 4). Two of these
had an AMSTAR score ≥8 [22,33].
Hyaluronic acid derivative was more effective than
standard care in one meta-analysis (AMSTAR score ≥8)
[22]. Low frequency low intensity noncontact ultrasound
was more effective than sharps debridement in two meta-
analyses (AMSTAR score ≥8) [33] and Chinese herbal
medicine (see Additional file 4 for the exact preparation)
plus unspecified standard therapy was more effective than
standard therapy alone in another meta-analysis [35].
Proportion of patients with healed wounds
Fifteen systematic reviews including 18 meta-analyses
[17-20,22,24,27,28,35,38,46,47,57-59] (Table 4; Additional
file 4) examined the proportion of patients with healed
diabetic foot and leg ulcers. Eight of these had an AMSTAR
score ≥8 [17,18,20,22,24,27,28,59].
Hydrogel dressings were more effective than basic
wound dressings, basic contact dressings, and gauze in
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[17,19,28]. Artificial skin grafts were more effective than
usual care in one meta-analysis [58] and skin replacement
therapy was more effective than usual care in another
[47]. Chinese herbal medicine (see Additional file 4 for the
exact preparation) plus unspecified standard therapy was
more effective than standard therapy alone in a meta-
analysis [35] and subcutaneous or intravenous granulocyte
colony-stimulating factor was more effective than usual
care in another (AMSTAR score ≥8) [24]. Finally, a meta-
analysis found platelet-rich plasma more effective than
control [38].
Outcome results for pressure ulcers
The following outcome results were only reported in
systematic reviews without meta-analysis: wound area/
size reduction (n = 3) [78,87,94] and time to healing or
rate of healing (n = 3) [68,78,94]. Details of these study
results can be found in Additional file 6.
Ulcer healing
Five systematic reviews reporting on eight meta-analyses
[16,43,60,64,62] and 11 systematic reviews without a
meta-analysis [75,76,78,85,90,92,94,97,99,104,106] (Table 5;
Additional files 4 and 6) focused on pressure ulcer healing.
Of these, eight had an AMSTAR score ≥8 [16,60,62,
64,75,76,90,106].
Hydrocolloid dressings were more effective than usual
care in a meta-analysis (AMSTAR score ≥8) [64], elec-
trotherapy was more effective than sham therapy in
another meta-analysis (AMSTAR score ≥8) [62], and
air-fluidized beds were more effective than standard
care or conventional mattresses in three meta-analyses
[43,60,125]. In addition, alternate foam mattresses were
more effective than standard foam mattresses in a meta-
analysis (AMSTAR score ≥8) [60].
Proportion of patients with healed wounds
Three systematic reviews including 25 meta-analyses
[43,54,62] and two systematic reviews without a meta-
analysis [78,94] (Table 5; Additional files 4 and 6) exam-
ined the proportion of patients with healed pressure ul-
cers. Only one had an AMSTAR score ≥8 [62].
One meta-analysis found that hydrocolloid dressings
were more effective than traditional dressings and an-
other that hydrogel dressings were more effective than
hydrocolloid dressings [43]. Different brands of alternat-
ing pressure mattresses were more effective than others
in a meta-analysis [43].
Outcome results for mixed complex wounds (unspecified)
Wound area/size reduction
Four systematic reviews including five meta-analyses
examined the area/size reduction of mixed complexwounds (unspecified) [21,32,41,42] (Table 6; Additional
file 4). Two had an AMSTAR score ≥8 [41,42]. Silver-
impregnated dressings were more effective than dressings
not containing silver in a meta-analysis (AMSTAR score ≥8)
[41]. Topical negative pressure was more effective than
standard wound care in another meta-analysis [32].
Ulcer healing
One systematic review including a meta-analysis [63]
and five systematic reviews without a meta-analysis
[91,100,105,107,111] (Table 6; Additional files 4 and 6)
examined ulcer healing for mixed complex wounds.
Three had an AMSTAR score ≥8 [91,107,111].
Proportion of patients with healed wounds
Five systematic reviews including 10 meta-analyses
[21,55,58,61,62] (Table 6; Additional file 4) examined the
proportion of patients with healed complex wounds. Two
had an AMSTAR score ≥8 [55,62]. Hydrocolloid dressings
were more effective than conventional dressings in a
meta-analysis [61] and ultrasound was more effective than
no ultrasound in another (AMSTAR score ≥8) [62]. In
addition, artificial skin grafts were more effective than
standard care in three meta-analyses [58].
Outcome results for surgical wound infections
The following outcome results were only reported in sys-
tematic reviews without meta-analysis: wound area/size
reduction (n = 2) [71,108], time to healing or rate of heal-
ing (n = 5) [68,71,96,108,109], and ulcer healing (n = 2)
[71,108]. Details of these study results can be found in
Additional file 6.
Proportion of patients with healed wounds
One systematic review including a meta-analysis (AMSTAR <8)
found that topical negative pressure was more effective
than standard treatment [37] (Table 7; Additional file 4).
Length of hospital stay
One systematic review and meta-analysis (AMSTAR <8)
found that vacuum-assisted closure was more effective
than conventional therapy for decreasing the length of
hospital stay associated with surgical wound infections
[26] (Table 7; Additional file 4).
Discussion
We conducted a comprehensive overview of systematic
reviews to identify optimal interventions for complex
wounds. Data from 99 systematic reviews were scruti-
nized and interventions that are likely optimal were
identified. These reviews examined numerous treatments
and comparators and used different outcomes to assess
effectiveness. Frequently, treatments considered as the
intervention in one review were administered to the
Tricco et al. BMC Medicine  (2015) 13:89 Page 20 of 23control in another. This renders the interpretation of
our findings difficult.
We found that some interventions are likely to be ef-
fective based on data from systematic reviews including
a meta-analysis with an AMSTAR score ≥8. For venous
leg ulcers, four-layer bandages [44,45], elastic high com-
pression [62], oral pentoxifylline with (or without) com-
pression [30], compression bandages (multi-layer, elastic)
[62,67], high compression [62] or multi-layer stockings
[45], and wound cleansing with cadexomer iodine plus
compression therapy [36] were effective compared with
usual care. Only four-layer bandages [45] were effective
in healing mixed arterial/venous leg ulcers versus com-
pression systems. For diabetic foot/leg ulcers, subcutane-
ous or intravenous granulocyte colony-stimulating factor
[24], hyaluronic acid derivative [22], low frequency, low
intensity noncontact ultrasound [33], and hydrogel
dressings [17,28] were effective interventions compared
with usual care. For pressure ulcers, hydrocolloid dress-
ings [64], electrotherapy [62], air-fluidized beds [60], and
alternate foam mattresses [60] were effective compared
with usual care. For mixed complex wounds, silver
dressings [41] and ultrasound [62] were found to be
more effective than no treatment. Finally, effective treat-
ments were not identified for surgical wound infections
amongst those with an AMSTAR score ≥8 including a
meta-analysis. It is important to note that many of these
interventions had conflicting results versus other com-
parators or were based on meta-analyses including few
studies with a small number of patients. As such, these
results should be interpreted with caution.
There are some limitations to our overview of system-
atic reviews. An inherent drawback of including system-
atic reviews is that the studies included in each of the
reviews will have been published well before the search
date. The inclusion of close to 100 systematic reviews,
however, provides a breadth of information that is un-
likely to significantly change with the inclusion of re-
cently published studies. Although we appraised the
methodological quality of the included reviews, we did
not assess the risk of bias in the included studies in the
systematic reviews. This is because a risk of bias tool for
systematic reviews currently does not exist, but we are
aware of one being developed by the Cochrane Collabor-
ation [126]. Furthermore, we only included systematic
reviews that were disseminated in English due to re-
source constraints. However, we attempted contacting
authors to receive English translations. In addition, al-
though we included five unpublished systematic reviews,
we attempted to obtain unpublished data from a further
10 systematic reviews that were available as conference
abstracts, yet we didn’t receive a response from the re-
view authors. As such, our findings are likely representa-
tive of published literature written in English. Since wedid not conduct a meta-analysis, we were unable to for-
mally test for publication bias.
Our results suggest the need for a network meta-
analysis [127], given the numerous interventions and
comparators available and examined across the litera-
ture. Policy-makers focus their decisions at the systems
level so require information on all treatment compari-
sons available. Patients and their healthcare providers
need to know if the treatment they are prescribed or
recommending is the most effective and safest compared
with all others available. Conducting a high-quality,
comprehensive systematic review and network meta-
analysis is the only feasible tool available to examine
multiple treatment comparisons. As the healthcare sys-
tem shifts towards more complex problems and a
resource-scarce environment, systematic reviews and
meta-analysis of only one treatment comparison become
obsolete. This is indeed the case for complex wound
care interventions; despite the availability of almost 100
systematic reviews, optimal management is still unclear.
Network meta-analysis also allows the ranking of all
treatments for each effectiveness and safety outcome ex-
amined, making it a particularly attractive tool for
decision-makers.
Almost half of the included systematic reviews were
rated as being of high methodological quality according to
the AMSTAR tool [13]. Consistent methodological short-
comings include not using a protocol to guide their con-
duct, not including a list of excluded studies at the full-
text level of screening, and not addressing or referring to
publication bias. Results reported in systematic reviews
with higher scores on the AMSTAR tool are likely the
most reliable. Furthermore, some studies only gave wound
care patients two days of treatment or followed patients
for two days. The utility of these short studies is question-
able and studies of longer duration are recommended.
Conclusions
In conclusion, our results confirm that there are numer-
ous interventions that can be utilized for patients with
complex wounds. However, few treatments were consist-
ently effective throughout the literature. Clinicians and pa-
tients can use our results as a guide towards tailoring
effective treatment according to type of wound. Planned
future analysis of this data through network meta-analysis
will further assist decision-makers as it will permit mul-
tiple treatment comparisons as well as the ranking of the
effectiveness of all available wound care interventions.
Additional files
Additional file 1: Classification of wound care interventions and
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